New Study Indicates MS May Worsen During Menopause
Researchers at the University of California – San Francisco found that menopause onset is associated with increased functional decline and…
Categories
Latest Blog Posts
- New Study Indicates MS May Worsen During Menopause
- Dept of Transportation Enacts Protections for Airline Passengers with Disabilities
- A Practical Approach to Managing Patients With Myasthenia Gravis—Opinions and a Review of the Literature
- Big Changes to Medicare Drug Coverage
- Town Hall Meeting – New Frontier of Multiple Sclerosis, treatments and more
- Understanding Lhermitte’s Phenomenon in MS
- video: Treating Multiple Sclerosis: Are They Doing It Wrong? – by Aaron Boster, MD
- 6 Things To Know About Dietary Supplements Marketed for Weight Loss
- Yes, I LIVE and BREATHE MULTIPLE SCLEROSIS
- Restless legs syndrome in multiple sclerosis patients
- Can MS Symptoms Fluctuate Throughout the Day?
- Insurance restrictions are harming people with multiple sclerosis! – Watch this video from Aaron Boster, MD to learn more
- Yes, You Have MS and You also might be a caregiver to your aging parents
- A LOOK at Holistic & Mainstream Approaches to Multiple Sclerosis
- What to Do When Cold Weather Worsens MS Symptoms
- How MS Causes Memory Loss and 5 Tips To Help With Forgetfulness
- Risks of Comorbidities With Multiple Sclerosis
- The Differences Between Heart Failure and Other Common Cardiac Conditions
- Treating Multiple Sclerosis: Are They Doing It Wrong?
- PRESS RELEASE : Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis